Price Alert

Becton Dickinson and (BDXA)

NYSE: BDXA · Real-Time Price · USD

59.24

-1.36 (-2.24%)

At close: Apr 30, 2020, 10:02 PM

-2.24% (1D)

Bid	n/a
Market Cap	55.91B
Revenue (ttm)	n/a
Net Income (ttm)	n/a
EPS (ttm)	2.763
PE Ratio (ttm)	21.440463264567498
Forward PE	n/a
Analyst	n/a
Dividends	n/a

Ask	n/a
Volume	6,151,137
Avg. Volume (20D)	0
Open	60.76
Previous Close	60.60
Day's Range	58.91 - 62.32
52-Week Range	49.07 - 64.12
Beta	n/a
Ex-Dividend Date	n/a

About BDXA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BDXA

Website n/a

Full Company Profile

News

1 month ago · seekingalpha.com

Becton, Dickinson: Great Time To Buy This Dividend Aristocrat

BDX is now attractively valued with a forward PE of 13.7, well below its historical average, making it a compelling value stock. Strong growth in Pharmaceutical Systems and Interventional segments, ma...

1 month ago · benzinga.com

Becton Dickinson Q3 Beats Estimates On Medical Device Boom

As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company BDX are reporting robust financial performances that highlight their resilience a...

1 month ago · reuters.com

Becton Dickinson joins peer in raising annual profit forecast after results beat

Becton Dickinson raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for its drug-delivery devices.

2 months ago · marketwatch.com

Becton Dickinson gets its spinoff deal, but the stock is still falling

Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.